URGENT: This Altcoin Opportunity Won’t Wait – Act Now

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Alistair Macdonald net worth and biography

Alistair Macdonald Biography and Net Worth

CEO of Syneos Health

He joined our Company in 2002 and has served in various senior leadership roles during that time. Prior to his current role, Mr. Macdonald most recently served as our President from January 2015 to October 2016 and as Chief Operating Officer from January 2013 to October 2016. He also served as President, Clinical Development Services from March 2012 to January 2013, Executive Vice President of our Global Oncology Unit from February 2011 to March 2012, Executive Vice President, Strategic Development from October 2009 to February 2011, and Senior Vice President, Biometrics from May 2002 to September 2009.

Mr. Macdonald currently serves on the Board of Directors of the Association of Clinical Research Organizations and Medicines Discovery Catapult, an independent, not-for-profit company, funded by an agency of the UK government. Mr. Macdonald received his Master of Science in Environmental Diagnostics from Cranfield University.

What is Alistair Macdonald's net worth?: The estimated net worth of Alistair Macdonald is at least $8.62 million as of April 9th, 2021. Mr. Macdonald owns 200,470 shares of Syneos Health stock worth more than $8,616,201 as of December 13th. This net worth approximation does not reflect any other assets that Mr. Macdonald may own. Learn More about Alistair Macdonald's net worth.
How do I contact Alistair Macdonald?: The corporate mailing address for Mr. Macdonald and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected]. Learn More on Alistair Macdonald's contact information.
Has Alistair Macdonald been buying or selling shares of Syneos Health?: Alistair Macdonald has not been actively trading shares of Syneos Health during the last quarter. Most recently, Alistair Macdonald sold 35,553 shares of the business's stock in a transaction on Tuesday, August 3rd. The shares were sold at an average price of $87.96, for a transaction totalling $3,127,241.88. Learn More on Alistair Macdonald's trading history.
Who are Syneos Health's active insiders?: Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (CEO, Non-Executive Director and Advisor), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Alistair Macdonald Insider Trading History at Syneos Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/3/2021	Sell	35,553	$87.96	$3,127,241.88
4/9/2021	Sell	14,039	$80.00	$1,123,120.00	200,470
4/1/2021	Sell	17,398	$77.61	$1,350,258.78	231,907
2/2/2021	Sell	64,497	$75.71	$4,883,067.87
12/22/2020	Sell	1,200	$70.02	$84,024.00	245,487
8/3/2020	Sell	10,289	$65.07	$669,505.23
7/14/2020	Sell	5,173	$58.68	$303,551.64	264,809
2/13/2019	Sell	8,143	$53.00	$431,579.00
2/5/2019	Sell	6,697	$53.04	$355,208.88
9/18/2017	Sell	2,348	$54.60	$128,200.80	99,453
8/17/2017	Sell	8,828	$55.65	$491,278.20	110,629
7/3/2017	Sell	10,555	$58.38	$616,200.90	83,935
5/1/2017	Sell	9,467	$45.00	$426,015.00	83,935
3/3/2017	Sell	8,828	$45.00	$397,260.00	83,296
1/20/2017	Sell	1,375	$50.50	$69,437.50	52,854
1/5/2017	Sell	14,840	$52.19	$774,499.60	69,069
8/17/2016	Sell	8,828	$43.80	$386,666.40	63,057
7/11/2016	Sell	9,468	$40.19	$380,518.92	28,144
12/31/2015	Sell	159,599	$47.46	$7,574,568.54	8,699
12/7/2015	Sell	42,959	$44.63	$1,917,260.17	55,681
9/28/2015	Sell	44,522	$39.93	$1,777,763.46	55,681

Alistair Macdonald Buying and Selling Activity at Syneos Health

Syneos Health Company Overview

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

Today's Range

Now: $42.98

$42.97

$42.99

50 Day Range

MA: $42.86

$42.48

$42.98

2 Week Range

Now: $42.98

$22.89

$52.23

Volume

7,386,200 shs

Average Volume

1,924,736 shs

Market Capitalization

$4.46 billion

P/E Ratio

62.29

Dividend Yield

N/A

Beta

1.58